Search Results - Jim Ranger‐Moore

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Clinical validation of p16/Ki‐67 dual‐stained cytology triage of <scp>HPV</scp> ‐positive women: Results from the <scp>IMPACT</scp> trial

    Clinical validation of p16/Ki‐67 dual‐stained cytology triage of <scp>HPV</scp> ‐positive women: Results from the <scp>IMPACT</scp> trial by Thomas C. Wright, Mark H. Stoler, Jim Ranger‐Moore, Qijun Fang, Patrick Volkir, Mahboobeh Safaeian, Ruediger Ridder

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    A gene-protein assay for human epidermal growth factor receptor 2 (HER2): brightfield tricolor visualization of HER2 protein, the HER2 gene, and chromosome 17 centromere (CEN17) in formalin-fixed, paraffin-embedded breast cancer tissue sections

    A gene-protein assay for human epidermal growth factor receptor 2 (HER2): brightfield tricolor visualization of HER2 protein, the HER2 gene, and chromosome 17 centromere (CEN17) in... by Hiroaki Nitta, Brian Kelly, Mary Padilla, Nikolaus Wick, Patrick Brunhoeber, Isaac Bai, Shalini Singh, Jim Ranger‐Moore, Chris Bieniarz, Hitoshi Tsuda, Thomas M. Grogan

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    HER2 intratumoral heterogeneity analyses by concurrent HER2 gene and protein assessment for the prognosis of HER2 negative invasive breast cancer patients

    HER2 intratumoral heterogeneity analyses by concurrent HER2 gene and protein assessment for the prognosis of HER2 negative invasive breast cancer patients by Sasagu Kurozumi, Mary Padilla, Masafumi Kurosumi, Hiroshi Matsumoto, Kenichi Inoue, Jun Horiguchi, Izumi Takeyoshi, Tetsunari Oyama, Jim Ranger‐Moore, D. Craig Allred, Eslie Dennis, Hiroaki Nitta

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Silver In Situ Hybridization (SISH) For Determination of HER2 Gene Status in Breast Carcinoma

    Silver In Situ Hybridization (SISH) For Determination of HER2 Gene Status in Breast Carcinoma by Bettina G. Papouchado, Jonathan Myles, Ricardo V. Lloyd, Mark H. Stoler, André M. Oliveira, Erinn Downs‐Kelly, Adrienne Morey, Michael Bilous, Ray B. Nagle, Nichole Prescott, Lin Wang, Lidija Dragovich, Abigail S. McElhinny, Carole Ferrell Garcia, Jim Ranger‐Moore, Heather L Free, William C. Powell, Margaret Loftus, James Pettay, Fabien Gaire, Christopher Roberts, Manfred Dietel, Patrick C. Roche, Thomas M. Grogan, Raymond Tubbs

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: